Impact of BCL2 polymorphisms on survival in transitional cell carcinoma of the bladder

A Polymorphism (rs1801018, Thr7Thr) of BCL2 is Associated with Papillary Thyroid Cancer in Korean Population

(2011) Young Gyu Eun et al.   Clinical and Experimental Otorhinolaryngology

Regulatory BCL2 promoter polymorphism (−938C>A) is associated with adverse outcome in patients with prostate carcinoma

(2011) Hagen S. Bachmann et al.   INTERNATIONAL JOURNAL OF CANCER

Predictors of Outcome of Non–Muscle-Invasive and Muscle-Invasive Bladder Cancer

(2011) Ramy F. Youssef et al.   TheScientificWorldJOURNAL

Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008

(2010) Jacques Ferlay et al.   INTERNATIONAL JOURNAL OF CANCER

A map of human genome variation from population-scale sequencing

(2010) Richard M. Durbin et al.   NATURE

Hardy-Weinberg Equilibrium Testing of Biological Ascertainment for Mendelian Randomization Studies

(2009) Santiago Rodriguez et al.   AMERICAN JOURNAL OF EPIDEMIOLOGY

The regulatory BCL2 promoter polymorphism (-938C>A) is associated with relapse and survival of patients with oropharyngeal squamous cell carcinoma

(2009) G. F. Lehnerdt et al.   ANNALS OF ONCOLOGY

Genetic variants in the candidate genes of the apoptosis pathway and susceptibility to chronic myeloid leukemia

(2009) D. H. Kim et al.   BLOOD

Interaction between BCL2 and Interleukin-10 Gene Polymorphisms Alter Outcomes of Diffuse Large B-Cell Lymphoma following Rituximab Plus CHOP Chemotherapy

(2009) Y. H. Park et al.   CLINICAL CANCER RESEARCH

The bcl2 −938CC Genotype Has Poor Prognosis and Lower Survival in Renal Cancer

(2009) Hiroshi Hirata et al.   JOURNAL OF UROLOGY

BCL2 gene polymorphism could predict the treatment outcomes in acute myeloid leukemia patients

(2009) Joon Ho Moon et al.   LEUKEMIA RESEARCH

Genetic Variants in Apoptosis and Immunoregulation-Related Genes Are Associated with Risk of Chronic Lymphocytic Leukemia

(2008) A. Enjuanes et al.   CANCER RESEARCH